As of November 7, 2026, 3 holders' latest Schedule 13D or 13G filings report owning 5% or more of Surgery Partners, Inc. The largest reported stake is BCPE Seminole Holdings LP's, at 22.96%. 15 filings are on record since July 7, 2025 (Schedule 13D/A, October 26, 2026).
Sell to companies like Surgery Partners, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: JANUS HENDERSON GROUP Ltd. · Sole voting: 0 · Shared voting: 6,421,539 · Sole dispositive: 0 · Shared dispositive: 6,421,539 · SCHEDULE 13G/A, 2026-11-06
- · Reporting person: BCPE Seminole Holdings LP · Sole voting: 0 · Shared voting: 10,708,102 · Sole dispositive: 0 · Shared dispositive: 10,708,102 · SCHEDULE 13D/A, 2026-10-26
- · Reporting person: Glenview Capital Management, LLC · Sole voting: 0 · Shared voting: 7,023,338 · Sole dispositive: 0 · Shared dispositive: 7,023,338 · SCHEDULE 13G, 2026-10-13
- · Reporting person: King Street Capital Management, L.P. · Sole voting: 0 · Shared voting: 6,058,141 · Sole dispositive: 0 · Shared dispositive: 6,058,141 · SCHEDULE 13G, 2026-08-14
- · Holder: Pentwater Capital Management LP · Percent: 9.7% · SCHEDULE 13G/A
Surgery Partners, Inc. has 15 Schedule 13D or 13G filings on record since 2025-07-07. 3 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| BCPE Seminole Holdings LP | 22.96% | 10,708,102 | SCHEDULE 13D/A, 2026-10-26 | 2026-10-23 |
| Pentwater Capital Management LP | 9.7% | 12,655,000 | SCHEDULE 13G/A, 2026-05-15 | 2026-03-31 |
| Glenview Capital Management, LLC | 5.4% | 7,023,338 | SCHEDULE 13G, 2026-10-13 | 2026-10-06 |
| JANUS HENDERSON GROUP Ltd. | 4.9% | 6,421,539 | SCHEDULE 13G/A, 2026-11-06 | 2026-10-30 |
| King Street Capital Management, L.P. | 4.6% | 6,058,141 | SCHEDULE 13G, 2026-08-14 | 2026-06-30 |
| Fmr LLC | 1.7% | 2,191,465 | SCHEDULE 13G/A, 2026-05-06 | 2026-03-31 |
| Wellington Management Group LLP | 0% | 217 | SCHEDULE 13G/A, 2025-08-12 | 2025-06-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Holding shares or following this stake? See who's behind Surgery Partners, Inc. and the warning signs.
Free to see. No signup.
Keep reading
More on Surgery Partners, Inc. and the records around it.
Surgery Partners, Inc. elsewhere on the record
Companies that share a holder
- King Street Capital Management, L.P. also filed stake reports on 1 other company: New Fortress Energy Inc. (Oct 2026)
- GLENVIEW CAPITAL MANAGEMENT, LLC also filed stake reports on 6 other companies: Butterfly Network, Inc. (Aug 2026), DXC Technology Co (Aug 2026), MYRIAD GENETICS INC (Aug 2026)
- Pentwater Capital Management LP also filed stake reports on 20 other companies: AMC Entertainment Holdings, Inc. (Aug 2026), Caesars Entertainment, Inc. (Aug 2026), Centessa Pharmaceuticals plc (Aug 2026)
Watch Surgery Partners, Inc.
Get an email when Surgery Partners, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Surgery Partners, Inc.?
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Surgery Partners, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Surgery Partners, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
15 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| BCPE Seminole Holdings LP | 0 | 10,708,102 | 0 | 10,708,102 | SCHEDULE 13D/A, 2026-10-26 |
| BCPE Seminole Holdings II Intermediate, LP | 0 | 30,055,197 | 0 | 30,055,197 | SCHEDULE 13D/A, 2026-10-26 |
| BCPE Seminole Holdings III, L.P. | 0 | 7,832,450 | 0 | 7,832,450 | SCHEDULE 13D/A, 2026-10-26 |
| BCPE Seminole Holdings IV, L.P. | 0 | 1,351,223 | 0 | 1,351,223 | SCHEDULE 13D/A, 2026-10-26 |
| Glenview Capital Management, LLC | 0 | 7,023,338 | 0 | 7,023,338 | SCHEDULE 13G, 2026-10-13 |
| Robbins Larry | 0 | 7,023,338 | 0 | 7,023,338 | SCHEDULE 13G, 2026-10-13 |
| JANUS HENDERSON GROUP Ltd. | 0 | 6,421,539 | 0 | 6,421,539 | SCHEDULE 13G/A, 2026-11-06 |
| King Street Capital Management, L.P. | 0 | 6,058,141 | 0 | 6,058,141 | SCHEDULE 13G, 2026-08-14 |
| King Street Capital Management GP, L.L.C. | 0 | 6,058,141 | 0 | 6,058,141 | SCHEDULE 13G, 2026-08-14 |
| Brian J. Higgins | 0 | 6,058,141 | 0 | 6,058,141 | SCHEDULE 13G, 2026-08-14 |
The latest filing identifies Surgery Partners, Inc. by CUSIP 86881A100 and gives its principal executive office as 310 SEVEN SPRINGS WAY, SUITE 500, BRENTWOOD, TN 37027 (SCHEDULE 13G/A, 2026-11-06).
What the percentages are based on
As of the date hereof, each of the Reporting Persons may be deemed the beneficial owner of approximately 5.4% of the Shares outstanding. (There were 130,918,260 Shares outstanding as of August 3, 2026, based on the Issuer's quarterly report on Form 10-Q filed on August 10, 2026.)Glenview Capital Management, LLC, SCHEDULE 13G, 2026-10-13
The percentages set forth in this Schedule 13G are calculated based upon an aggregate of 130,918,260 shares of common stock outstanding as of August 3, 2026, as reported in the Company's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026, filed with the Securities and Exchange Commission on August 10, 2026.King Street Capital Management, L.P., SCHEDULE 13G, 2026-08-14
Purpose of Transaction (Item 4)
BCPE Seminole Holdings LP
Item 4 of the Initial Statement is hereby amended and supplemented by adding the following at the end of Item 4 of the Initial Statement: As disclosed by the Issuer in its Current Report on Form 8-K, filed with the Securities and Exchange Commission on October 26, 2026, on October 23, 2026 the Issuer entered into an Agreement and Plan of Merger (the "Merger Agreement") with Spyglass Topco, LLC, a Delaware limited liability company ("Parent"), Spyglass Merger Subsidiary, Inc., a Delaware corporation and a wholly-owned subsidiary of Parent ("Merger Subsidiary"), and, solely for the limited purposes set forth therein, Bon Secours Mercy Health, Inc., a Maryland nonstock, nonprofit corporation ("Guarantor"), pursuant to which Merger Subsidiary will merge (the "Merger") with and into the Issuer, with the Issuer surviving the Merger as a wholly owned subsidiary of Parent (the "Surviving Corporation") on the terms and subject to the conditions set forth in the Merger Agreement. Concurrently with the execution and delivery of the Merger Agreement, and as a condition to the willingness of Parent, Merger Subsidiary and Guarantor to enter into the Merger Agreement, BCPE Seminole Holdings, LP, BCPE Seminole Holdings II Intermediate, LP, BCPE Seminole Holdings III, LP and BCPE Seminole Holdings IV, LP (collectively, the "Reinvestment Stockholders") entered into a Voting and Support Agreement (the "Support Agreement") with Parent and the Issuer. Under the Support Agreement, the …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-10-26; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-07 | Janus Henderson Group Plc | 10.1% | SCHEDULE 13G/A |
| 2025-08-12 | Wellington Management Group LLP | 0% | SCHEDULE 13G/A |
| 2025-08-14 | Pentwater Capital Management LP | 5.5% | SCHEDULE 13G |
| 2025-11-14 | King Street Capital Management, L.P. | 7.2% | SCHEDULE 13G |
| 2025-11-14 | Pentwater Capital Management LP | 9.1% | SCHEDULE 13G/A |
| 2025-11-14 | Janus Henderson Group Plc | 10.2% | SCHEDULE 13G/A |
| 2026-02-05 | Fmr LLC | 5.1% | SCHEDULE 13G/A |
| 2026-02-17 | Pentwater Capital Management LP | 7.7% | SCHEDULE 13G/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-05-06 | Fmr LLC | 1.7% | SCHEDULE 13G/A |
| 2026-05-15 | Pentwater Capital Management LP | 9.7% | SCHEDULE 13G/A |
| 2026-08-14 | King Street Capital Management, L.P. | 4.6% | SCHEDULE 13G |
| 2026-10-13 | Glenview Capital Management, LLC | 5.4% | SCHEDULE 13G |
| 2026-10-26 | BCPE Seminole Holdings LP | 22.96% | SCHEDULE 13D/A |
| 2026-11-06 | JANUS HENDERSON GROUP Ltd. | 4.9% | SCHEDULE 13G/A |
Questions about who owns Surgery Partners, Inc.
Who owns Surgery Partners, Inc.?
On this page, 3 holders' latest ownership filings report 5% or more of Surgery Partners, Inc.: BCPE Seminole Holdings LP (22.96%, Schedule 13D/A, filed 2026-10-26), Pentwater Capital Management LP (9.7%, Schedule 13G/A, filed 2026-05-15) and Glenview Capital Management, LLC (5.4%, Schedule 13G, filed 2026-10-13).
Who are the largest shareholders of Surgery Partners, Inc.?
By the share each holder's latest filing reports, the largest holders of Surgery Partners, Inc. on this page are BCPE Seminole Holdings LP (22.96%), Pentwater Capital Management LP (9.7%) and Glenview Capital Management, LLC (5.4%).
When did BCPE Seminole Holdings LP buy into Surgery Partners, Inc.?
The filings give report dates, not purchase dates. The earliest filing from BCPE Seminole Holdings LP on this page is the Schedule 13D/A, filed 2026-10-26, reporting 22.96%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 15 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Surgery Partners, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.